CARAGLIA, Michele

CARAGLIA, Michele  

Dipartimento di Medicina di Precisione  

Risultati 1 - 20 di 516 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 1-gen-2016 Zappavigna, S.; Scuotto, M.; Cossu, A. M.; Ingrosso, Diego; DE ROSA, Mario; Schiraldi, Chiara; Filosa, Rosanna; Caraglia, Michele
5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells 1-gen-1994 Caraglia, Michele; Pinto, A; Correale, P; Zagonel, V; Genua, G; Leardi, A; Pepe, S; Bianco, Ar; Tagliaferri, P.
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 1-gen-2012 Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor 1-gen-1999 Budillon, A; DI GENNARO, E; Caraglia, Michele; Barbarulo, D; Abbruzzese, A; Tagliaferri, P.
A case of clear renal cell cancer associated to meningioma and verrucous carcinoma of frontal region in an old patient 1-gen-2007 Vetrano, A; Addeo, R; Russo, I; Meo, G; DE ROSA, G; D'Anna, F; Caraglia, Michele
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 1-gen-2007 Santini, D; Vincenzi, B; Caraglia, Michele; Tonini, G.
A liver angioma colonized by colon cancer cells in a patient with two primitive localizations by colon adenocarcinoma: biologic, diagnostic and therapeutic implications 1-gen-2005 Facchini, G; Fiore, F; Caraglia, Michele; D'Angelo, R; Nasti, G; Caponigro, F; Formato, R; Budillon, A; Iaffaioli, Rv
A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology 1-gen-2007 Ottaiano, A; Budillon, A; Normanno, N; Iaffaioli, Vr; Caraglia, Michele
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 1-gen-2011 Addeo, R; Caraglia, Michele; De Santi, Ms; Montella, L; Abbruzzese, A; Parlato, Ciro; Vincenzi, B; Carraturo, M; Faiola, V; Genovese, M; Cennamo, G; Del Prete, S.
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma 1-gen-2004 Correale, P; Messinese, S; Caraglia, Michele; Marsili, S; Piccolomini, A; Petrioli, R; Ceciarini, F; Micheli, L; Nencini, C; Neri, A; Vuolo, G; Guarnieri, A; Abbruzzese, A; Prete, Sd; Giorgi, G; Francini, G.
Acetylation of proteins as novel target for antitumor therapy: review article 1-gen-2004 DI GENNARO, E; Bruzzese, F; Caraglia, Michele; Abruzzese, A; Budillon, A.
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. 1-gen-2013 Milone, Mr; Pucci, B; Bruzzese, F; Carbone, C; Piro, G; Costantini, S; Capone, F; Leone, A; Di Gennaro, E; Caraglia, Michele; Budillon, A.
Adenoid cystic carcinoma of the larynx in a 70-year-old patient: A case report 1-gen-2018 Ricciardiello, F;  Addeo, R;  Di Lullo, Am; Abate, Antonio;  Mazzone, S; Oliva, F;  Motta, G; Caraglia, M;  Mesolella, M
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells. 1-gen-2007 Naviglio, Silvio; Spina, Annamaria; Marra, M.; Sorrentino, A.; Chiosi, Emilio; Romano, M.; Improta, S.; Budillon, A.; Illiano, G.; ABBRUZZESE SACCARDI, A.; Caraglia, Michele
AdoMet triggers apoptosis in head and neck squamous cancer by inducing ER stress and potentiates cell sensitivity to cisplatin 1-gen-2019 Mosca, Laura; Pagano, Martina; Ilisso, Concetta Paola; Cave, Donatella Delle; Desiderio, Vincenzo; Mele, Luigi; Caraglia, Michele; Cacciapuoti, Giovanna; Porcelli, Marina
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 1-gen-2014 Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol 1-gen-2021 Ottaiano, A.; Scala, S.; Santorsola, M.; Trotta, A. M.; D'Alterio, C.; Portella, L.; Clemente, O.; Nappi, A.; Zanaletti, N.; De Stefano, A.; Avallone, A.; Granata, V.; Notariello, C.; Luce, A.; Lombardi, A.; Picone, C.; Petrillo, A.; Perri, F.; Tatangelo, F.; Di Mauro, A.; Albino, V.; Izzo, F.; Rega, D.; Pace, U.; Di Marzo, M.; Chiodini, P.; De Feo, G.; Del Prete, P.; Botti, G.; Delrio, P.; Caraglia, M.; Nasti, G.
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 1-gen-2017 Ricciardiello, Filippo; Caraglia, Michele; Iorio, Brigida; Abate, Teresa; Boccellino, Mariarosaria; Colella, Giuseppe; Oliva, Flavia; Ferrise, Pierpaolo; Zappavigna, Silvia; Faenza, Mario; Ferraro, Giuseppe A.; Sequino, Giulio; Nicoletti, Giovanni Francesco; Mesolella, Massimo
Alpha-Interferon And Its Effects On Signal Transduction Pathways 1-gen-2005 Caraglia, Michele; Marra, M.; Pelaia, G.; Maselli, R.; Caputi, M.; Marsico, S. A.; ABBRUZZESE SACCARDI, A.
Alpha-interferon and its effects on signalling pathways within cells 1-gen-2004 Caraglia, Michele; Vitale, G; Marra, M; Budillon, A; Tagliaferri, P; Abbruzzese, A.